Glycorex Transplantation AB Stock
Equities
GTAB B
SE0000524530
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 SEK | -3.59% | +0.47% | -35.09% |
Sales 2021 | 29.01M 2.74M | Sales 2022 | 37.39M 3.53M | Capitalization | 303M 28.63M |
---|---|---|---|---|---|
Net income 2021 | -12M -1.13M | Net income 2022 | -8M -756K | EV / Sales 2021 | 22.5 x |
Net cash position 2021 | 33.08M 3.13M | Net cash position 2022 | 23.52M 2.22M | EV / Sales 2022 | 7.47 x |
P/E ratio 2021 |
-56.1
x | P/E ratio 2022 |
-35.3
x | Employees | 23 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 95.58% |
1 day | -3.59% | ||
1 week | +0.47% | ||
Current month | +0.94% | ||
1 month | -5.70% | ||
3 months | -16.50% | ||
6 months | -49.41% | ||
Current year | -35.09% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Laven
CEO | Chief Executive Officer | 51 | 21-12-31 |
Founder | 71 | 95-12-31 | |
Sales & Marketing | - | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 95-12-31 | |
Nils Siegbahn
CHM | Chairman | 71 | 99-12-31 |
Clas Runnberg
BRD | Director/Board Member | 72 | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.86 | -3.59% | 20,092 |
24-05-27 | 0.892 | +0.45% | 2,845 |
24-05-24 | 0.888 | +3.26% | 17,960 |
24-05-23 | 0.86 | +1.18% | 61,371 |
24-05-22 | 0.85 | -0.70% | 110,295 |
End-of-day quote NORDIC GROWTH MARKET, May 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-35.09% | 6.21M | |
+9.12% | 28.11B | |
-35.22% | 3.03B | |
-21.21% | 2.39B | |
+5.74% | 2.18B | |
-11.31% | 1.9B | |
+21.11% | 1.88B | |
+23.77% | 1.3B | |
+13.02% | 1.23B | |
-5.10% | 1.23B |
- Stock Market
- Equities
- GTAB B Stock